Pilot study using carboplatin (C), docetaxel (T) and capecitabine (X) before and during radiotherapy (RT) with concurrent boost as an organ-preservation strategy for locally advanced head and neck squamous cell carcinoma (HNSCC)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 5607-5607
2015 ◽
Vol 5
(5)
◽
pp. 343-349
◽
Keyword(s):